Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol
about
Primary treatment of Crohn’s disease: combined antibiotics taking center stageIn vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosisIn vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICsVitamins A & D inhibit the growth of mycobacteria in radiometric cultureThe thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in cultureOn the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis.On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis.On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosisGrowth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.Mycobacterium avium subsp. paratuberculosis in Veterinary MedicineAntibacterial and antimycobacterial treatment for inflammatory bowel disease.Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycinZoonotic potential of Mycobacterium avium ssp. paratuberculosis: the current position.Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.On the etiology of Crohn disease.In vitro susceptibility of Mycobacterium ulcerans to clarithromycinRHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection."In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease.
P2860
Q22241483-303CF493-6278-4EFE-8163-A374D4AB8CA2Q28344762-D8C4355C-17E9-4983-AED7-C3933BEF4613Q28369523-93EA7D7D-4532-44D8-9BF1-BE7E418992D5Q28378598-1A8F6731-D903-4973-B6C8-320EAE2F1BBAQ28740534-8F302630-BBE2-43A1-BB2B-701045656B80Q28751585-F3E4489E-EDA0-4FF9-8D4B-D37C7B3964D4Q33270273-8D44B4BA-A876-421C-BDF3-D0CDAF1E8473Q33287467-00C9EA90-3A0B-48FB-8669-43B604BEEACEQ33346257-396BF62D-D3A1-4B53-98C0-C7503FF5141DQ33723503-A86EFDA3-2330-4BB4-B423-F1F722BA510FQ33975716-48C601CD-441E-4720-A74B-1029227A0819Q34399158-2AEE347C-8213-4670-9C25-D3E3736FB478Q35111440-30EB4ECC-4FEB-4FE1-A9FD-601EC3E94F07Q35125517-BAB9609E-4DEC-4676-8D2C-003EFAF36C7AQ35904249-23344A44-C533-4379-980B-3D3F7790530BQ36139416-0BE6B212-4185-419E-B33D-BA34D14832F0Q37092384-65B1E149-2D93-4C21-9F9E-EA6927D51781Q37364320-C2984B21-C3A0-4767-92C8-4A2042322D35Q39364483-0DFCFD84-9216-470C-B001-0202FD11F281Q39679682-9BC83AEC-E6C4-4CC5-952E-743ACF03EF19Q39867298-D755DC12-BDE9-4712-A123-4B960B88A055Q41503375-C90FD9F6-8202-481A-9A2E-173EED999128Q43817637-AD95E4C4-66B6-4CF2-AD1D-01B55FF9DEDC
P2860
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Activity of clarithromycin com ...... lular activities by ethambutol
@ast
Activity of clarithromycin com ...... lular activities by ethambutol
@en
type
label
Activity of clarithromycin com ...... lular activities by ethambutol
@ast
Activity of clarithromycin com ...... lular activities by ethambutol
@en
prefLabel
Activity of clarithromycin com ...... lular activities by ethambutol
@ast
Activity of clarithromycin com ...... lular activities by ethambutol
@en
P2093
P2860
P356
P1476
Activity of clarithromycin com ...... lular activities by ethambutol
@en
P2093
P2860
P304
P356
10.1128/AAC.36.12.2843
P407
P577
1992-12-01T00:00:00Z